Browse all clinical trials

Sponsor Updatedsort icon
Phase I Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer Bristol-Myers Squibb 2009-05-20
Phase II A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects Bristol-Myers Squibb 2009-05-20
Integrated Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD) Department of Veterans Affairs 2009-05-20
Phase II Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance Bristol-Myers Squibb 2009-05-20
Phase I Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin National Cancer Institute (NCI) 2009-05-20
Phase III Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-05-20
Diagnostic Challenges in IC (and Male CPPS) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-05-20
Phase I Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery National Cancer Institute (NCI) 2009-05-20
Phase I Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors Infinity Pharmaceuticals 2009-05-20
Phase III Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer National Cancer Institute (NCI) 2009-05-20
Phase III Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer National Cancer Institute (NCI) 2009-05-20
Phase I Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies GlaxoSmithKline 2009-05-20
Phase III Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Eastern Cooperative Oncology Group 2009-05-20
Phase II Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer National Cancer Institute (NCI) 2009-05-20
Phase I A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction Bristol-Myers Squibb 2009-05-20
Phase II Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis Bristol-Myers Squibb 2009-05-20
Phase II Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Accelerated Phase) Subjects Bristol-Myers Squibb 2009-05-20
Phase II Phase II, 2nd Line Melanoma - RAND Monotherapy Bristol-Myers Squibb 2009-05-20
Phase I A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies Bristol-Myers Squibb 2009-05-20
Phase I A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection Bristol-Myers Squibb 2009-05-20
Phase III Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-Resistant Virus Bristol-Myers Squibb 2009-05-20
Phase II This is a Study of Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer Bristol-Myers Squibb 2009-05-20
Phase III Study to Evaluate the Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in HIV-Infected Subjects Evidencing Virologic Suppression Bristol-Myers Squibb 2009-05-20
Phase III A Study of Abatacept in Patients With Active Ulcerative Colitis Bristol-Myers Squibb 2009-05-20
Compliance With LDL-Lowering Therapy (Study P05467) Schering-Plough 2009-05-20